Category: Include on Menu

The agreement expands Premier Graphene’s presence in advanced materials by targeting graphene-enabled ballistic protection systems and supporting its long-term vertical integration strategy. Key Investor Takeaways Why BIEI Stock Is in Focus Premier Graphene (USOTC:BIEI) announced that its affiliate, HGI Industrial Technologies, has entered into a strategic joint venture with Canada’s Nova Graphene to develop, manufacture…

The company increased its U.S. patent portfolio to 82 applications while advancing regulatory, engineering and testing milestones for its Texatron Fusion Engine platform. Key Investor Takeaways Why (USOTC:AMFN) Stock Is in Focus American Fusion (USOTC:AMFN) announced the filing of six new U.S. patent applications related to its proprietary Texatron Fusion Engine platform, bringing its total…

The court’s decision allows VoIP-Pal to refine its federal antitrust claims while narrowing the litigation to focus on alleged violations of the Sherman Act. Key Investor Takeaways Why (USOTC:VPLM) Stock Is in Focus VoIP-Pal.com (USOTC:VPLM) announced that the U.S. District Court for the District of Columbia has granted the company permission to file an amended…

The reverse stock split is designed to restore compliance with Nasdaq’s minimum bid price requirement while reducing the company’s outstanding share count to approximately 850,000 shares. Key Investor Takeaways Why (NASDAQ:ONFO) Stock Is in Focus Onfolio Holdings (NASDAQ:ONFO) announced it will complete a 1-for-50 reverse stock split as part of its effort to regain compliance…

The company delivered a second consecutive quarter of GAAP profitability while continuing to invest in AI-driven commerce capabilities and maintaining its full-year financial outlook. Key Investor Takeaways Why CMRC Stock Is in Focus Commerce (NASDAQ:CMRC) reported second-quarter revenue of $84.5 million, broadly unchanged from a year earlier, while Gross Merchandise Volume (GMV) increased 14% to…

Strong commercial momentum for BRINSUPRI and continued growth from ARIKAYCE prompted Insmed to raise its 2026 outlook and increase peak revenue expectations for its lead programmes. Key Investor Takeaways Why INSM Stock Is in Focus Insmed (NASDAQ:INSM) reported total second-quarter 2026 revenue of $425.5 million, driven by continued commercial strength from BRINSUPRI, which generated $309.2…

Record quarterly revenue, improving margins and continued commercial momentum are prompting Iovance to reassess its full-year guidance while advancing multiple late-stage clinical programmes. Key Investor Takeaways Why (NASDAQ:IOVA) Stock Is in Focus Iovance Biotherapeutics (NASDAQ:IOVA) delivered record second-quarter revenue of approximately $99.3 million, a 66% increase from the prior-year quarter and a 39% improvement over…

The healthcare company has introduced two new research-use PCR tests as demand for cyclospora detection grows during an ongoing U.S. outbreak. Key Investor Takeaways Why RHHBY Stock Is in Focus Roche (USOTC:RHHBY) announced the launch of two new real-time PCR assays designed to detect Cyclospora cayetanensis, the parasite responsible for cyclosporiasis, as laboratories seek additional…

The joint venture significantly expands SurgePays’ nationwide distribution network and supports its long-term goal of exceeding one million wireless subscribers. Key Investor Takeaways Why SURG Stock Is in Focus SurgePays (NASDAQ:SURG) announced the creation of Redline Wireless Group, a joint venture designed to accelerate the distribution of its prepaid wireless services across one of the…

The transaction adds a clinical-stage pain therapy with FDA Orphan Drug Designation while providing funding expected to support development through Phase 2 data and into registrational planning. Key Investor Takeaways Why ENSC Stock Is in Focus Ensysce Biosciences (NASDAQ:ENSC) has completed its acquisition of private biotechnology company Cy Biopharma, bringing clinical-stage drug candidate CY200 into…